Dr. Dixon Dehority, MD

NPI: 1376538439
Total Payments
$1,024
2024 Payments
$91.79
Companies
15
Transactions
59
Medicare Patients
977
Medicare Billing
$140,016

Payment Breakdown by Category

Food & Beverage$1,024 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,024 59 100.0%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $275.00 15 $0 (2024)
Merck Sharp & Dohme LLC $134.30 9 $0 (2023)
Sunovion Pharmaceuticals Inc. $109.20 7 $0 (2019)
Janssen Pharmaceuticals, Inc $86.71 5 $0 (2024)
Otsuka America Pharmaceutical, Inc. $76.16 4 $0 (2019)
Lundbeck LLC $67.16 3 $0 (2019)
Boehringer Ingelheim Pharmaceuticals, Inc. $60.73 3 $0 (2019)
AstraZeneca Pharmaceuticals LP $44.22 3 $0 (2019)
GlaxoSmithKline, LLC. $35.94 2 $0 (2018)
Novo Nordisk Inc $32.23 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $91.79 5 Novartis Pharmaceuticals Corporation ($50.45)
2023 $23.45 1 Merck Sharp & Dohme LLC ($23.45)
2022 $23.91 1 Abbott Laboratories ($23.91)
2020 $17.18 1 PFIZER INC. ($17.18)
2019 $356.10 21 Boehringer Ingelheim Pharmaceuticals, Inc. ($60.73)
2018 $402.53 23 Novartis Pharmaceuticals Corporation ($157.63)
2017 $109.41 7 Sunovion Pharmaceuticals Inc. ($61.27)

All Payment Transactions

59 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
11/13/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $16.11 General
Category: Cardiology/Vascular Diseases
10/30/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $18.26 General
Category: HFCWO
09/19/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $17.43 General
Category: Cardiology/Vascular Diseases
07/12/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $16.91 General
Category: Cardiology/Vascular Diseases
06/17/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $23.08 General
Category: Cardiovascular & Metabolism
03/15/2023 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $23.45 General
Category: CARDIOVASCULAR
06/15/2022 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $23.91 General
Category: Cardiac Rhythm Management
09/24/2020 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $17.18 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/17/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.90 General
Category: Cardiovascular & Metabolism
11/07/2019 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $19.35 General
Category: CARDIOVASCULAR
11/06/2019 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $17.86 General
Category: NEPHROLOGY
10/24/2019 Lundbeck LLC NORTHERA (Drug) Food and Beverage Cash or cash equivalent $19.28 General
Category: NEUROLOGY
10/14/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $15.02 General
Category: RESPIRATORY
10/11/2019 Novo Nordisk Inc Tresiba (Drug), Victoza, Xultophy 100/3.6 Food and Beverage In-kind items and services $17.85 General
Category: Diabetes
10/08/2019 Merck Sharp & Dohme Corporation ZERBAXA (Drug), SIVEXTRO Food and Beverage In-kind items and services $13.70 General
Category: INFECTIOUS DISEASE
09/16/2019 Novo Nordisk Inc Tresiba (Drug), Victoza Food and Beverage In-kind items and services $14.38 General
Category: Diabetes
09/06/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $17.40 General
Category: RESPIRATORY
07/29/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $15.51 General
Category: RESPIRATORY
07/17/2019 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $16.23 General
Category: Cardiovascular and Metabolism
07/15/2019 Lilly USA, LLC BASAGLAR (Drug) Food and Beverage In-kind items and services $14.11 General
Category: Diabetes
05/24/2019 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug) Food and Beverage In-kind items and services $19.14 General
Category: NEPHROLOGY
05/23/2019 Boehringer Ingelheim Pharmaceuticals, Inc. SPIRIVA RESPIMAT (Drug) Food and Beverage In-kind items and services $20.39 General
Category: RESPIRATORY
05/02/2019 Merck Sharp & Dohme Corporation ZERBAXA (Drug), SIVEXTRO Food and Beverage In-kind items and services $12.09 General
Category: INFECTIOUS DISEASE
04/29/2019 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $16.58 General
Category: CARDIOVASCULAR
04/09/2019 Boehringer Ingelheim Pharmaceuticals, Inc. SPIRIVA RESPIMAT (Drug) Food and Beverage In-kind items and services $23.53 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 284 299 $168,038 $38,017
2022 2 203 209 $98,692 $30,328
2021 5 275 301 $120,156 $39,808
2020 3 215 220 $92,187 $31,863
Total Patients
977
Total Services
1,029
Medicare Billing
$140,016
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 284 299 $168,038 $38,017 22.6%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 156 162 $77,448 $24,284 31.4%
99220 Initial hospital observation care per day, typically 70 minutes Facility 2022 47 47 $21,244 $6,044 28.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 179 183 $83,997 $28,209 33.6%
99220 Hospital observation care, typically 70 minutes Facility 2021 56 56 $23,632 $7,515 31.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 15 31 $5,115 $1,695 33.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 13 19 $4,484 $1,468 32.7%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 12 12 $2,928 $921.03 31.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 142 147 $64,557 $22,983 35.6%
99220 Hospital observation care, typically 70 minutes Facility 2020 55 55 $22,270 $7,054 31.7%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 18 18 $5,360 $1,825 34.1%

About Dr. Dixon Dehority, MD

Dr. Dixon Dehority, MD is a Family Medicine healthcare provider based in Matthews, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376538439.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dixon Dehority, MD has received a total of $1,024 in payments from pharmaceutical and medical device companies, with $91.79 received in 2024. These payments were reported across 59 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,024).

As a Medicare-enrolled provider, Dehority has provided services to 977 Medicare beneficiaries, totaling 1,029 services with total Medicare billing of $140,016. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Hospitalist
  • Location Matthews, NC
  • Active Since 09/15/2005
  • Last Updated 05/10/2024
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1376538439

Products in Payments

  • ENTRESTO (Drug) $240.66
  • XARELTO (Drug) $86.71
  • ZERBAXA (Drug) $71.86
  • NORTHERA (Drug) $67.16
  • BROVANA (Drug) $61.27
  • SAMSCA (Drug) $58.30
  • LONHALA MAGNAIR (Drug) $47.93
  • SPIRIVA RESPIMAT (Drug) $43.92
  • LEQVIO (Drug) $34.34
  • Tresiba (Drug) $32.23
  • BRILINTA (Drug) $29.18
  • DIFICID (Drug) $26.15
  • CONFIRM RX (Device) $23.91
  • VERQUVO (Drug) $23.45
  • SMARTVEST (Device) $18.26
  • BREO (Drug) $18.20
  • JYNARQUE (Drug) $17.86
  • TRELEGY ELLIPTA (Drug) $17.74
  • ELIQUIS (Drug) $17.18
  • Baxdela (Drug) $16.09

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Matthews